home / stock / hcat / hcat news


HCAT News and Press, Health Catalyst Inc

Stock Information

Company Name: Health Catalyst Inc
Stock Symbol: HCAT
Market: NYSE

Menu

HCAT HCAT Quote HCAT Short HCAT News HCAT Articles HCAT Message Board
Get HCAT Alerts

News, Short Squeeze, Breakout and More Instantly...

HCAT - Health Catalyst: Stellar Earnings Growth Projected

2024-06-26 17:20:29 ET Summary Today, we take a look at Health Catalyst, Inc., which is projected to have a surge in earnings over the next two fiscal years. Management has big plans to grow revenues and adjusted EBITDA in the coming years, and the company has a considerable amoun...

HCAT - (HCAT) Pivots Trading Plans and Risk Controls

2024-06-22 03:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

HCAT - Health Catalyst completes acquisition of Carevive Systems

2024-06-06 09:01:56 ET More on Health Catalyst Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible Health Catalyst Non-GAAP EPS of $0.05 beats by $0.02, revenue of $74.72M misses by $0.09M t Read the full article on Seeking Alpha For further de...

HCAT - Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive

Health Catalyst Acquires Oncology-Focused Health Technology Company Carevive PR Newswire SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services t...

HCAT - Underperform Recommendation Issued On HCAT By Raymond James

2024-05-21 18:30:04 ET Raymond James analyst issues UNDERPERFORM recommendation for HCAT on May 21, 2024 04:00PM ET. The previous analyst recommendation was Underperform. HCAT was trading at $6.77 at issue of the analyst recommendation. The overall analyst consensus : BU...

HCAT - Buy Recommendation Issued On HCAT By Wells Fargo

2024-05-21 18:30:04 ET Wells Fargo analyst issues BUY recommendation for HCAT on May 21, 2024 04:00PM ET. The previous analyst recommendation was Buy. HCAT was trading at $6.77 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...

HCAT - Health Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite®

Health Catalyst Unveils Next-Generation Data and Analytics Ecosystem Built for Healthcare, Health Catalyst Ignite® PR Newswire SALT LAKE CITY , May 21, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of da...

HCAT - Health Catalyst, Inc. (HCAT) Q1 2024 Earnings Call Transcript

2024-05-09 22:50:25 ET Health Catalyst, Inc. (HCAT) Q1 2024 Earnings Conference Call May 09, 2024, 17:00 ET Company Participants Jack Knight - VP, Investor Relations Daniel Burton - CEO & Director Jason Alger - CFO Conference Call Participants Jar...

HCAT - Health Catalyst Non-GAAP EPS of $0.05 beats by $0.02, revenue of $74.72M misses by $0.09M

2024-05-09 17:07:28 ET More on Health Catalyst Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible Health Catalyst, Inc. (HCAT) Q4 2023 Earnings Call Transcript Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade) Health Ca...

HCAT - Health Catalyst Reports First Quarter 2024 Results

SALT LAKE CITY, May 09, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2024. “For the...

Next 10